Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma
Clinical trial NCT03214250 · COMPLETED
Trial details
- NCT number
- NCT03214250
- Sponsor
- Parker Institute for Cancer Immunotherapy
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-21
- Primary completion
- 2021-02-11
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.